[ad_1]
(News)
– Conversations within the FDA, CDC and NIH have started regarding COVID-19 booster injections, with the Biden administration indicating plans will gain momentum early next month to implement this plan to the general population. “Agencies are engaged in a rigorous, science-based process to determine if or when a recall may be necessary,” an FDA representative said Thursday, via CNN. But one group, the immunocompromised, may need these extra injections faster than the general public, or even older patients, and federal officials say the Biden administration is accelerating plans for this demographic, with the possibility of ” an authorization in a few weeks, or even a few days, by the Washington post and ABC News. That would cover millions of Americans who are cancer patients or organ recipients, or who have other conditions that make them particularly vulnerable to COVID.
If the data confirms, the FDA should revise the emergency use authorizations already in place for vaccines in the United States so that those who qualify can obtain these vaccines. Abroad, Israel is currently offering boosters for the immunocompromised and for all those 60 and over, and countries like France, Britain and Germany are expected to follow suit. Some patients in the United States are already going rogue, receiving extra doses of the unauthorized vaccine “as they see fit,” resulting in a “really difficult” dilemma, a doctor at Massachusetts General Hospital told the United States. To post. Some say that the word “boosters” is not even the right term when it comes to extra doses for the immunocompromised. The CDC’s vaccine advisory committee is scheduled to meet next Friday. (Read more stories about the coronavirus vaccine.)
[ad_2]
Source link